Bronwen Bastone Enfusion, Inc. (ENFN) insider trading activity

Bronwen Bastone is Chief People Officer of Enfusion, Inc.. Currently has a direct ownership of 195,694 shares of ENFN, which is worth approximately $1.71 Million. The most recent transaction as insider was on Sep 10, 2024, when has been sold 3,219 shares (Class A Common Stock) at a price of $8.12 per share, resulting in proceeds of $26,138. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 196K

1.62% 3M change

26.54% 12M change

Total Value Held $1.71 Million

Bronwen Bastone Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 10 2024	SELL Open market or private sale	$26,138 $8.12 p/Share	3,219 Reduced 1.62%	195,694 Class A Common Stock
Jun 20 2024	SELL Open market or private sale	$147,934 $8.11 p/Share	18,241 Reduced 8.4%	198,913 Class A Common Stock
Jun 18 2024	SELL Open market or private sale	$86,103 $8.17 p/Share	10,539 Reduced 4.63%	217,154 Class A Common Stock
May 20 2024	SELL Open market or private sale	$325,263 $9.55 p/Share	34,059 Reduced 13.01%	227,693 Class A Common Stock
Mar 01 2024	SELL Payment of exercise price or tax liability	$16,525 $8.67 p/Share	1,906 Reduced 0.72%	261,752 Class A Common Stock
Mar 01 2024	BUY Grant, award, or other acquisition	$476,584 $4.34 p/Share	109,812 Added 29.4%	263,658 Class A Common Stock
Jan 09 2024	SELL Open market or private sale	$3,669 $8.95 p/Share	410 Reduced 0.27%	153,846 Class A Common Stock
Jan 08 2024	SELL Open market or private sale	$3,608 $9.23 p/Share	391 Reduced 0.25%	154,256 Class A Common Stock
Sep 11 2023	SELL Payment of exercise price or tax liability	$28,065 $8.82 p/Share	3,182 Reduced 2.02%	154,647 Class A Common Stock
Aug 17 2023	SELL Payment of exercise price or tax liability	$1,546 $8.18 p/Share	189 Reduced 0.12%	157,829 Class A Common Stock
Aug 17 2023	BUY Grant, award, or other acquisition	-	558 Added 0.35%	158,018 Class A Common Stock
Aug 16 2023	SELL Payment of exercise price or tax liability	$2,453 $7.94 p/Share	309 Reduced 0.2%	157,460 Class A Common Stock
Aug 16 2023	BUY Grant, award, or other acquisition	-	914 Added 0.58%	157,769 Class A Common Stock
Aug 14 2023	SELL Open market or private sale	$323 $7.89 p/Share	41 Reduced 0.03%	156,855 Class A Common Stock
Aug 11 2023	SELL Open market or private sale	$356 $8.1 p/Share	44 Reduced 0.03%	156,779 Class A Common Stock
Aug 11 2023	BUY Grant, award, or other acquisition	-	117 Added 0.07%	156,896 Class A Common Stock
Aug 10 2023	SELL Open market or private sale	$404 $8.08 p/Share	50 Reduced 0.03%	156,693 Class A Common Stock
Aug 10 2023	BUY Grant, award, or other acquisition	-	130 Added 0.08%	156,823 Class A Common Stock
Aug 09 2023	SELL Open market or private sale	$457 $8.32 p/Share	55 Reduced 0.04%	156,602 Class A Common Stock
Aug 09 2023	BUY Grant, award, or other acquisition	-	141 Added 0.09%	156,743 Class A Common Stock
Aug 08 2023	BUY Grant, award, or other acquisition	-	153 Added 0.1%	156,657 Class A Common Stock
Jun 15 2023	SELL Payment of exercise price or tax liability	$95,884 $8.87 p/Share	10,810 Reduced 6.46%	156,504 Class A Common Stock
Jun 15 2023	BUY Grant, award, or other acquisition	-	1,285 Added 0.76%	167,314 Class A Common Stock
May 24 2023	SELL Payment of exercise price or tax liability	$8,818 $7.93 p/Share	1,112 Reduced 0.67%	166,029 Class A Common Stock
May 24 2023	BUY Grant, award, or other acquisition	-	3,298 Added 1.94%	167,141 Class A Common Stock

Bronwen Bastone

Chief People Officer

Chicago, IL

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ENFN shares.

Notify only if

Value

Insider Trading

Get notified when an Enfusion, Inc. insider buys or sells ENFN shares.

Notify only if

Operation

Value

Type

News

Receive news related to Enfusion, Inc.

Track Activities on ENFN

Account